Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo

Inflammatory Bowel Disease

Clinical research in pediatric inflammatory bowel disease centers on optimizing infliximab treatment and maintaining response over time, with attention to treatment durability and therapeutic effectiveness.

  • Infliximab therapy
  • Therapeutic drug monitoring
  • Pediatric gastroenterology

The sponsor’s work in this area is focused on improving management of chronic intestinal inflammation in children.

Urinary Tract Infections

Research on febrile urinary tract infections addresses individualized antibiotic therapy in children, with interest in reducing recurrence and refining treatment duration after fever resolves.

  • Amoxicillin and clavulanic acid
  • Recurrent infection prevention
  • Paediatric infectious diseases

This area reflects a clinical focus on improving infection control and antibiotic use in childhood urinary infections.

In White-Sutton syndrome, the sponsor is involved in studies targeting behavioral symptoms, adaptive functioning, and quality of life in affected patients.

  • Neurodevelopmental disorders
  • Behavioral symptom management
  • Adaptive behavior assessment

The therapeutic interest in this rare disorder includes support for cognitive, social, and daily living skills.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Testing Personalized Antibiotic Treatment with Amoxicillin and Clavulanic Acid for Children with Febrile Urinary Tract Infections

    Not yet recruiting

    1 1 1 1
    Italy
  • Study on Perampanel for Improving Behavior and Quality of Life in Patients with White-Sutton Syndrome

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Italy
  • Study on the Effectiveness of Infliximab for Children with Inflammatory Bowel Disease

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Italy